Abstract:
1. A MEMBER OF THE GROUP CONSISTING OF A COMPOUND HAVING THE FORMULA:
2,2,3-TRI(R1),4-(PYRIDIN-4-YL-),5-X,7-R2-CHROMANE
AND A COMPOUND HAVING THE FORMULA:
2,2,7-TRI(R1),4-(PYRIDIN-4-YL-),5-Y-CHROMENE
AND A NON-TOXIC ACID ADDITION SALT THEREOF, WHEREIN R1 IS LOWER ALKYL HAVING 1 TO 6 CARBON ATOMS, R2 IS STRAIGHT CHAIN ALKYL HAVING 1 TO 20 CARBON ATOMS, 2-HEPTYL, METHYLOCTYL, OR CYCLOALKYL-LOWER-ALKYL, THE CYCLOALKYL PART HAVING 3 TO 8 CARBON ATOMS, AND X IS LOWER ALKOXY OR STRAIGHT CHAIN ALKANOLOXY OF 2 TO 20 CARBON ATOMS, BENZOYLOXY, NAPHTHOYLOXY, PHOSPHATE, CARBONATE, MALONATE, SUCCINATE, CITRATE, PHOSPHATE, HEMISUCCINATE, OR LOWER ALKYL CARBONATE, EXCLUSIVE OF AMINO ACID ESTERS.
Abstract:
PHENYL AND SUBSTITUTED PHENYL PYRIDO BENZAZEPINES AND BENZOQUINOLIZINES, E.G. 11(4-CHLOROPHENYL)-1,3,4MATETRAHYDRO-2H-BENZO - (B) - QUINOLIZINE-6-(11H)-ONE, AND 12-HYDROXY-12-PHENYL- PYRIDO - (1,2-B)(2) -BENZAZEPIN-6ONE, ARE USEFUL AS MAJOR TRANQUILIZERS.
Abstract:
A - (3 - BENZOYL-2-METHYLINDOLIZUN-1-YL) PROPIONIC ACID AND ITS PHARMACUTICALLY ACCEPTABLE NON-TOXIC SALTS AS ANALGESIC AND ANTI-INFLAMMATORY AGENTS.
Abstract:
WHEREIN R1 IS HYDROGEN LOWERALKANOYL, CYCLOALKYLLOWERALKYL, LOWERALKYL, CYCLOALKYLLOWERALKANOYL, LOWERALKENYL, LOWERALKYNYL, HALOLOWERALKENYL, PHENYLLOWERALKYL, PHENYLLOWERALKENYL OR PHENYLLOWERALKNYL; R2 IS LOWERALKYL; R3 IS C1-C20 ALKYL OR CYCLOALKYLLOWERALKYL; N IS AN INTEGER FROM 1 TO 6; AND R4 IS HYDROGEN OR LOWERALKYL; AND THE PHARMACEUTICALLY ACCEPTALE ACID ADDITION SALTS THEREOF. TETRAHYDRO-5H-(1)BENZOPYRANO(4,3-C)PYRIDINE
2,2-DI(R1-),4-(PYRID-4-YL),5-X,7-R2-2H-CHROMENE (II)
2-(O=),4-(PYRID-4-YL),5-X,7-R2-2H-CHROMENE (III)
IN WHICH R1 IS LOWER ALKYL HAVING 1 TO 6 CARBON ATOMS, R2 IS ALKYL HAVING 1 TO 20 CARBON ATOMS OR CYCLOALKYLLOWER-ALKYL, THE CYCLOALKYL PART HAVING 3 TO 8 CARBON ATOMS, AND X IS OH OR A PHARMACEUTICALLY ACCEPTABLE SALT INCLUDING AN ALKALI METAL SALT, OR AN ETHER OR ESTER OF THE OHGROUP, EXCLUSIVE OF AMINO ACID ESTERS. COMPOUNDS I AND II POSSESS BENEFICIAL PHARMACODYNAMIC ACTIVITY WITH RESPECT TO THE CARDIOVASCULAR AND CENTRAL NERVOUS SYSTEM, AND COMPOUNDS III ARE INTERMEDIATES FOR USE IN THE PREPARATION OF COMPOUNDS I AND II.
Abstract:
4-AROMTIC BYCYCLO(2.2.2.)OCT-2-ENE-2-CARBOXYLIC ACIDS AND THEIR ESTERS WHICH ARE PREPARED BY THE REACTION OF A 3,6-DISBUSTITUTED A-PYRONE AND ETHYLENE AT ELEVATED TEMPERATURES ARE USEFUL AS INTERMEDIATES FOR THE PREPARATION OF 4-AROMATIC BICYCLO(2.2.2)OCTANE - 1 - AMINES USEFUL AS ANTI-DEPRESSANT.
Abstract:
THIS INVENTION CONCERNS 5.6,7,8-TETRAHYDRO-1,6-NAPHTHYRIDIN-2-OL ESTERS WHICH ARE PHARMACOLOGICALLY ACTIVE AS CENTRAL NERVOUS SYSTEM DEPRESSANTS.
Abstract:
A PROCESS FOR PRODUCING PYRIDINE CARBOXYLIC ACIDS BY OXIDIZLING ALKYL PYRIDINES IN THE LIQUID PHASE WITH A MOLECULAR OXYGEN-CONTAINING GAS IN THE PRESENCE OF A CATALYST CONSISTING OF ZIRCONIUM COMPOUNDS, SALTS OF OTHER TRANSITION METALS AND BROMINE COMPOUNDS.